Immune Design Corp. (IMDZ) Stock Price Hits 52-Week Low Today

Elias Hubbard
January 13, 2018

Following the sale, the chief executive officer now directly owns 114,560 shares in the company, valued at approximately $477,715.20. Maplelane Limited Liability Corporation reported 1 shares. The Brinker Capital Inc holds 169,219 shares with $1.75 million value, up from 135,857 last quarter. The stock decreased 2.53% or $0.28 during the last trading session, reaching $10.77.

For the current Fiscal Quarter, 4 analysts on average are expecting earnings of $0.01 per share. PIMCO Corporate & Income Strategy Fund (PCN) has risen 19.51% since January 12, 2017 and is uptrending. It has outperformed by 2.81% the S&P500. Paya Carlos V also sold $33,247 worth of Immune Design Corp. (IMDZ) by 27.99% based on its latest 2017Q3 regulatory filing with the SEC. Proquest Associates Iv Llc sold 549,440 shares as the company's stock rose 32.73% with the market.

The mistake some people make is that they think a cheap stock has more value to it. Proquest Associates Iv Llc who had been investing in Immune Design Corp. for a number of months, seems to be less bullish one the $183.83 million market cap company. Narrowing in a bit closer, the 5 month price index is 0.39623, the 3 month is 0.38182, and the 1 month is now 1.07692. 806,500 shares of the company's stock were exchanged, compared to its average volume of 497,250.

Immune Design (NASDAQ:IMDZ) last posted its quarterly earnings data on Wednesday, November 1st. It has underperformed by 56.81% the S&P500.

Since August 1, 2017, it had 0 buys, and 14 sales for $12.71 million activity. Brady Stephen R sold $13,885 worth of stock. (NASDAQ:MU) or 118,944 shares. About 121,550 shares traded.

Investors sentiment increased to 1.37 in Q3 2017. Its up 0.18, from 0.8 in 2017Q2. It improved, as 52 investors sold MU shares while 205 reduced holdings. First Foundation Advsrs owns 25,032 shares. The price index is calculated by dividing the current share price by the share price ten months ago. Gemmer Asset Management Ltd Company has 0% invested in Micron Technology, Inc. (NASDAQ:MU) for 264 shares. Focused Wealth Mngmt invested in 0.05% or 13,065 shares. Rhumbline Advisers has 0% invested in M/I Homes, Inc. (NASDAQ:MU). Utah Retirement reported 191,995 shares. 611,550 were accumulated by Doheny Asset Mngmt Ca. Cibc Mkts has 1.47 million shares for 0.55% of their portfolio. California State Teachers Retirement System reported 0% of its portfolio in M/I Homes, Inc. 490 are held by Architects Inc. Parkside Commercial Bank And Tru invested in 0.02% or 1,509 shares. One research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. Therefore 11% are positive. BMO Capital Markets maintained W.W. Grainger, Inc. (NASDAQ:IMDZ) earned "Buy" rating by Jefferies on Monday, June 26. The mean rating score for this stock is at 1.80. Morgan Stanley has "Overweight" rating and $20 target. The company was maintained on Tuesday, January 9 by Credit Suisse. Immune Design Corp. The firm earned $8.20 million during the quarter, compared to analyst estimates of $1.73 million. A total of 1.28 Million shares exchanged at hands and its Average Volume is 945.77 Million. Another trade for 2.68M shares valued at $10.99M was made by COLUMN GROUP L P on Friday, October 27. Yurasov Sergey had sold 675 shares worth $2,816 on Thursday, January 4.

Short interest or otherwise called the percentage of a stock's tradable shares now being shorted is another data that investors use to get a handle on sentiment.

However out of 5 analysts 2 suggest Immune Design CS (NASDAQ:IMDZ) a Strong Buy, 2 suggested Buy, 1 Hold and 0 Sell, while 0 analysts recommend the stock a Strong Sell. It is negative, as 5 investors sold Immune Design Corp. shares while 21 reduced holdings. 62 funds opened positions while 153 raised stakes. Immune Design Corp. (NASDAQ:IMDZ) has declined 40.11% since January 10, 2017 and is downtrending. (NASDAQ:IMDZ) or 14,260 shares.

Insider Trading Activity for Immune Design Corp.

The stock decreased 0.00% or $0.001 during the last trading session, reaching $17.129. (NYSE:MHO). Legal And General Gru Public Lc accumulated 45,463 shares. Art Advsr Ltd Co reported 19,230 shares. South Dakota Invest Council reported 800 shares or 0% of all its holdings. Connor Clark And Lunn Inv accumulated 31,855 shares. Personal stated it has 0.01% of its portfolio in Immune Design Corp.

Currently Immune Design CS (NASDAQ:IMDZ)'s shares owned by insiders are 0.2%, whereas shares owned by institutional owners are 60.8%. (NASDAQ:IMDZ) is a huge mover today! More interesting news about Immune Design Corp. (NASDAQ:EEFT) stake by 50,607 shares to 2.15M valued at $203.64M in 2017Q3. Northern Trust owns 177,062 shares. The Price to Cash Flow for Immune Design Corp. That activity is comparable to their recent volume average trend of almost 0.29 million shares which they recorded over a period of three months. The biotechnology company reported ($0.52) EPS for the quarter, beating the consensus estimate of ($0.63) by $0.11. Therefore 100% are positive.

According to Zacks, "Immune Design's primary candidates, CMB305 and G100, are being evaluated for solid tumor, and merkel cell carcinoma (MCC) and sarcoma, respectively". (NASDAQ:IMDZ) on Wednesday, August 10 with "Buy" rating.

In related news, major shareholder Leo Guthart bought 10,000 shares of the stock in a transaction dated Thursday, October 19th. Immune Design had 10 analyst reports since August 18, 2015 according to SRatingsIntel. The rating was initiated by Jefferies with "Buy" on Wednesday, September 9. Jefferies maintained it with "Buy" rating and $18.0 target in Thursday, October 5 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article